Amplification of KLF2 inhibits gastric cancer cell proliferation, migration, and invasion, thereby highlighting the association between KLF2 degradation and poor prognosis in gastric cancer.[27] DEK, considered an oncogenic factor in various cancer processes, is stabilized by Mettl3 through an m6A modification in gastric cancer. The gene discussed is KLF2; the disease is gastric cancer.